$DECN triple corrected. recovery. OTC $0.43 C
Post# of 11802
Posted On: 04/21/2016 5:14:50 PM
$DECN triple corrected.
recovery. OTC $0.43
Called 9/9/13 $0.30
Website
David-Goliath Fight
Over Glucose Tests For Diabetics
Hits Boiling Point Forbes
Wed, Apr 20)
Shares Outstanding: 25.16M
Float: 16.61M
% Held by Insiders: 15.45%
% Held by Institutions: N/A
Headlines
Decision Diagnostics Corp. develops smart phone based remote electronic medical record technologies. The company offers prescription drugs; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It distributes brand name rx and non-rx diagnostics products, as well as various lines of ostomy, wound care, and post-surgery medical products. The companys line of devices for blood glucose home testing includes Genstrip50 test strips, as well as concepts for blood testing monitors. Decision Diagnostics Corp. also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physicians practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. In addition, it offers IT services in various medical care markets by developing smart phone applications to be used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp was founded in 2000 and is based in Westlake Village, California .
recovery. OTC $0.43
Called 9/9/13 $0.30
Website
David-Goliath Fight
Over Glucose Tests For Diabetics
Hits Boiling Point Forbes
Wed, Apr 20)
Shares Outstanding: 25.16M
Float: 16.61M
% Held by Insiders: 15.45%
% Held by Institutions: N/A
Headlines
Decision Diagnostics Corp. develops smart phone based remote electronic medical record technologies. The company offers prescription drugs; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It distributes brand name rx and non-rx diagnostics products, as well as various lines of ostomy, wound care, and post-surgery medical products. The companys line of devices for blood glucose home testing includes Genstrip50 test strips, as well as concepts for blood testing monitors. Decision Diagnostics Corp. also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physicians practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. In addition, it offers IT services in various medical care markets by developing smart phone applications to be used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp was founded in 2000 and is based in Westlake Village, California .
(0)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼